Bruce Jackson
Stock Analyst at Benchmark Co.
(0.08)
# 4,598
Out of 4,639 analysts
301
Total ratings
37.4%
Success rate
-9.8%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintained: Buy | $250 → $185 | $144.70 | +27.85% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Maintained: Buy | $77 → $82 | $89.53 | -8.41% | 2 | Jul 31, 2026 | |
| NEO NeoGenomics | Maintained: Buy | $11 → $16 | $16.53 | -3.21% | 24 | Jul 24, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $18 → $13 | $5.00 | +160.00% | 11 | Jul 1, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $19.78 | +1.11% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Maintained: Buy | $1 → $2 | $0.71 | +181.69% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $3 | $1.22 | +145.90% | 20 | May 19, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $23.44 | - | 1 | May 11, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $145 → $120 | $109.72 | +9.37% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Maintained: Buy | $14 → $10 | $6.60 | +51.52% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $2.65 | +654.72% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $6 | $6.13 | -2.12% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $217 | $177.58 | +22.20% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $4.37 | +609.38% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.25 → $1 | $0.4864 | +105.59% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.70 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.7152 | - | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $140 | $0.45 | +31,011.11% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.02 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.7954 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.35 → $2 | $1.83 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $24 | $6.14 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.3636 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $0.4 | $0.0001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $24.94 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $4.43 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.8428 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $4 | $2.05 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.35 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.50 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.37 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.3238 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $48.48 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.32 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.12 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $17.37 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $90.68 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $51.19 | n/a | 2 | Mar 2, 2012 |
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $250 → $185
Current: $144.70
Upside: +27.85%
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: $77 → $82
Current: $89.53
Upside: -8.41%
NeoGenomics
Jul 24, 2026
Maintained: Buy
Price Target: $11 → $16
Current: $16.53
Upside: -3.21%
Unicycive Therapeutics
Jul 1, 2026
Maintained: Buy
Price Target: $18 → $13
Current: $5.00
Upside: +160.00%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $19.78
Upside: +1.11%
Humacyte
Jun 1, 2026
Maintained: Buy
Price Target: $1 → $2
Current: $0.71
Upside: +181.69%
Biofrontera
May 19, 2026
Maintained: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $23.44
Upside: -
Abbott Laboratories
Apr 17, 2026
Maintained: Buy
Price Target: $145 → $120
Current: $109.72
Upside: +9.37%
CapsoVision
Mar 27, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $6.60
Upside: +51.52%
Mar 20, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $2.65
Upside: +654.72%
Mar 16, 2026
Maintained: Buy
Price Target: $20 → $6
Current: $6.13
Upside: -2.12%
Mar 3, 2026
Maintained: Buy
Price Target: $187 → $217
Current: $177.58
Upside: +22.20%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $4.37
Upside: +609.38%
Nov 20, 2025
Maintained: Buy
Price Target: $1.25 → $1
Current: $0.4864
Upside: +105.59%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.70
Upside: -
Sep 15, 2025
Maintained: Hold
Price Target: n/a
Current: $0.7152
Upside: -
Sep 15, 2025
Maintained: Buy
Price Target: $280 → $140
Current: $0.45
Upside: +31,011.11%
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $2.02
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.7954
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $1.35 → $2
Current: $1.83
Upside: n/a
Apr 15, 2024
Maintained: Buy
Price Target: $40 → $24
Current: $6.14
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.3636
Upside: n/a
Mar 22, 2024
Maintained: Buy
Price Target: $4 → $0.4
Current: $0.0001
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $24.94
Upside: n/a
Aug 24, 2023
Maintained: Buy
Price Target: $9 → $5
Current: $4.43
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.8428
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $8 → $4
Current: $2.05
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.35
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $8
Current: $5.50
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.37
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.3238
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $48.48
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.32
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.12
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $17.37
Upside: n/a
Nov 21, 2012
Maintained: Hold
Price Target: $46
Current: $90.68
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $51.19
Upside: n/a